Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-21-000512
Filing Date
2021-04-26
Accepted
2021-04-26 14:44:46
Documents
1
Effectiveness Date
2021-04-26

Document Format Files

Seq Description Document Type Size
1 8A_Cert_PTIX.pdf CERT 251210
  Complete submission text file 0001354457-21-000512.txt   344267
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-12555 | Film No.: 21853416
SIC: 7389 Services-Business Services, NEC